Clinical evidence of interaction between clopidogrel and proton pump inhibitors

Clopidogrel is approved for reduction of atherothrombotic events in patients with cardiovascular (CV) and cerebrovascular disease. Dual antiplatelet therapy with aspirin and clopidogrel decreases the risk of major adverse cardiac events after acute coronary syndrome or percutaneous coronary interven...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lin, Shoa-Lin, Chang, Hui-Min, Liu, Chun-Peng, Chou, Li-Ping, Chan, Jaw-Wen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Co., Limited 2011
Pynciau:
Guidelines Clinical Practice
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110904/
https://ncbi.nlm.nih.gov/pubmed/21666816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v3.i5.153
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg